deltatrials

Axial spondyloarthritis Trials in Prague, Czechia

Conditions / Axial spondyloarthritis / Prague, Czechia

Axial spondyloarthritis has been the subject of sustained clinical investigation across multiple research sites.

10 total trials for this combination

Trials

NCT ID Title Status Phase
NCT04436640 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis ACTIVE_NOT_RECRUITING
NCT04436640 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis ACTIVE_NOT_RECRUITING
NCT07148414 A Study of SPY072 in Rheumatic Disease RECRUITING
NCT07148414 A Study of SPY072 in Rheumatic Disease RECRUITING
NCT02552212 Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS COMPLETED PHASE3
NCT03129100 A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis COMPLETED PHASE3
NCT04436640 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis ACTIVE_NOT_RECRUITING
NCT02757352 A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis COMPLETED PHASE3
NCT02438787 A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis TERMINATED PHASE3
NCT04436640 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis ACTIVE_NOT_RECRUITING

Related Pages